bpc-157 anti-inflammatory effects systemic as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers Thymosin Alpha & Beta and
Description
Sisto SA, Tapp W, Drastal S, Bergen M, DeMasi I, Cordero D, et al
In: Shils M, Shike M, Ross A, Caballero B, RJ C, eds
Molecules, 19(11), 1906619077
All forms are checked manually by the study supervisors before they are sent for computer entry
The FDA label includes a boxed warning regarding thyroid C-cell tumors observed in rodent studies, contraindicating use in patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
